DPPE-PEG2000-VIP
DPPE-PEG2000-VIP (DPPE-PEG2000-Mal-Cys-HSDAVFTDNYTRLRKQMAVKKYLNSILN) is a functionalized PEGylated phospholipid conjugate composed of three modular components: 1,2-dipalmitoyl-sn-glycerol-3-phosphoethanolamine (DPPE) as a lipid anchoring group, a 2000 Da polyethylene glycol (PEG) spacer arm, and a VIP peptide as a terminal targeting/functional ligand. DPPE-PEG2000-VIP can be used in research such as targeted drug delivery for breast cancer.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
제품 설명
In Vitro
DPPE-PEG2000-VIP is composed of three covalently linked components: 1. DPPE (1,2-dipalmitoyl-sn-glycerol-3-phosphoethanolamine): Lipid anchoring group-inserts into the lipid bilayer of liposomes/LNPs, providing stable membrane anchoring; its saturated C16 chain imparts bilayer rigidity. 2. PEG 2000 (polyethylene glycol, molecular weight 2000): Hydrophilic polymer spacer arm-forms a steric hindrance crown around nanoparticles, reducing opsonin activity and reticuloendothelial system (RES) clearance, prolonging circulating half-life, and providing spatial separation between the lipid surface and the targeting ligand. 3. VIP peptide: Targeting/functional ligand-VIP peptide (vasoactive intestinal peptide) is an endogenous neuropeptide that specifically binds to VIP receptors (VPAC1 and VPAC2) highly expressed on the surface of various tumor cells (especially breast cancer), achieving tumor-targeted delivery and targeting breast cancer stem cells.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
SMILES
[DPPE-PEG2000-VIP]
-
Synonyms
DPPE-PEG2000-Mal-Cys-HSDAVFTDNYTRLRKQMAVKKYLNSILN
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocol
-
Breast Cancer Modeling
Breast cancer is a heterogeneous cancer, and it has been distinguished into four subtypes: luminal A, luminal B, HER2-positive and basal-like. Molecular mutations, epigenetic alterations, hormone exposure and immune microenvironment are related to the progression of breast cancer.
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)